Kiyohara, Eiji http://orcid.org/0000-0002-0436-4296
Tanemura, Atsushi http://orcid.org/0000-0002-5239-8474
Sakura, Kazuma
Nakajima, Toshihiro
Myoui, Akira
Yamazaki, Naoya
Kiyohara, Yoshio
Katayama, Ichiro
Fujimoto, Manabu
Kaneda, Yasufumi
Funding for this research was provided by:
the project of translational and clinical research core centers
Article History
Received: 2 August 2021
Accepted: 25 November 2021
First Online: 5 January 2022
Declarations
:
: Toshihiro Nakajima is an employee of GenomIdea, Inc. Toshihiro Nakajima and Yasufumi Kaneda are stockholders (0.08% and 0.5%) in GenomIdea, Inc. The other authors declare no conflicts of interest.
: This study was performed with the approval of the ethics committee at Osaka University Hospital (No. 135903 on Dec 17, 2013). The project was allocated at the Medical Center for Translational Research, No. GEN101-JM001. All procedures involving human participants were carried out in accordance with the ethical standards of the Osaka University Hospital, national research committee (the University Hospital Medical Information Network-UMIN000012943), and in line with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Written informed consent for protocol therapy, the analysis of patient samples, and the use of data for research and publication were obtained from all individual participants prior to treatment in the study.